Cargando…
Intravenous thrombolysis in acute central retinal artery occlusion – A prospective interventional case series
BACKGROUND: No evidence-based therapy exists for non-arteritic central retinal artery occlusion (NA-CRAO). Retinal ischemic tolerance is low; irreversible damage occurs within four hours of experimental NA-CRAO. In previous randomized trials evaluating intra-arterial or intravenous thrombolysis (IVT...
Autores principales: | Schultheiss, Maximilian, Härtig, Florian, Spitzer, Martin S., Feltgen, Nicolas, Spitzer, Bernhard, Hüsing, Johannes, Rupp, André, Ziemann, Ulf, Bartz-Schmidt, Karl U., Poli, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973600/ https://www.ncbi.nlm.nih.gov/pubmed/29813111 http://dx.doi.org/10.1371/journal.pone.0198114 |
Ejemplares similares
-
Central retinal artery occlusion – detection score
por: Casagrande, Maria, et al.
Publicado: (2023) -
Inner Retinal Layer Hyperreflectivity Is an Early Biomarker for Acute Central Retinal Artery Occlusion
por: Wenzel, Daniel A., et al.
Publicado: (2022) -
Determination of Ischemia Onset Based on Automatically Generated Spectralis SD-OCT Values in Acute Central Retinal Artery Occlusion
por: Casagrande, Maria, et al.
Publicado: (2021) -
Intravenous thrombolysis in acute ischemic stroke after
antagonization of unfractionated heparin with protamine: case series and
systematic review of literature
por: Kneer, Katharina, et al.
Publicado: (2023) -
Hypothermia Protects and Prolongs the Tolerance Time of Retinal Ganglion Cells against Ischemia
por: Schultheiss, Maximilian, et al.
Publicado: (2016)